دورية أكاديمية

Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program

التفاصيل البيبلوغرافية
العنوان: Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
المؤلفون: de Moura, AlexandreAff1, Aff2, IDs41598023405699_cor1, Vuagnat, PerrineAff1, Aff2, Renouf, Benjamin, Pierga, Jean-YvesAff1, Aff3, Loirat, Delphine, Vaflard, Pauline, Lafayolle de la Bruyère, Charline, Chaumard-Billotey, Natacha, Hajjaji, NawaleAff6, Aff7, Ladoire, Sylvain, Dabakuyo, Sandrine, Patsouris, Anne, Frenel, Jean Sébastien, Nicolai, Vincent, Alexandre, Marie, Dohollou, Nadine, Grenier, Julien, Bourien, Heloïse, Bidard, François-ClémentAff1, Aff2
المصدر: Scientific Reports. 13(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20452322
DOI:10.1038/s41598-023-40569-9